| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Poplar Point Capital Partners LP is a 10% Owner at NovaBay Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 36 buys and 0 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2025 | NBY Novabay Pharmaceuticals, Inc. | 10% Owner | Buy | 28,731 | $0.56 | $15,966.98 | +0.7% | +40.1% | -26.4% | |
| Apr 1, 2025 | NBY Novabay Pharmaceuticals, Inc. | 10% Owner | Buy | 123,365 | $0.60 | $74,518.88 | +2.3% | -0.9% | -45.7% | |
| Mar 25, 2025 | NBY Novabay Pharmaceuticals, Inc. | 10% Owner | Buy | 49,927 | $0.62 | $30,717.93 | +1.0% | -6.6% | -53.4% | |
| Mar 18, 2025 | NBY Novabay Pharmaceuticals, Inc. | 10% Owner | Buy | 64,175 | $0.62 | $39,503.18 | +1.4% | -4.8% | -59.4% | |
| Mar 7, 2025 | NBY Novabay Pharmaceuticals, Inc. | 10% Owner | Buy | 48,930 | $0.61 | $29,857.74 | +1.1% | -1.7% | -53.7% | |
| Feb 24, 2025 | NBY Novabay Pharmaceuticals, Inc. | 10% Owner | Buy | 84,487 | $0.66 | $55,526.60 | +2.1% | -13.9% | -49.8% | |
| Jan 31, 2025 | NBY Novabay Pharmaceuticals, Inc. | 10% Owner | Buy | 102,388 | $0.66 | $67,700.16 | +9.6% | -11.3% | +179.5% |